Nishadil
Signup Signin
Delhi | 25°C (windy)
A New Dawn in Cancer Detection: Freenome's Bold Move Towards Public Markets

A New Dawn in Cancer Detection: Freenome's Bold Move Towards Public Markets
The Silent Shift: Cancer's Unsettling New Timeline

The Silent Shift: Cancer's Unsettling New Timeline
The Dawn of a New Era: Are Cancer Cures Finally Within Our Grasp?

The Dawn of a New Era: Are Cancer Cures Finally Within Our Grasp?
The Dawn of a New Era: How cT-DNA Blood Tests Are Transforming Cancer Surveillance

The Dawn of a New Era: How cT-DNA Blood Tests Are Transforming Cancer Surveillance
Guardant Health Shares Plummet as Landmark Cancer Test Trial Fails to Meet Primary Endpoint

Guardant Health Shares Plummet as Landmark Cancer Test Trial Fails to Meet Primary Endpoint
Load more..